What drugs does CARLSBAD make?

CARLSBAD has 10 FDA-approved drugs.

What therapeutic areas does CARLSBAD focus on?

CARLSBAD focuses primarily on Infectious Disease and Dermatology and 1 other therapeutic areas.

← Back

Data updated: Jun 28, 2026

CARLSBAD

Generics

Infectious Disease Dermatology Immunology

CARLSBAD is a generic drug manufacturer focused on Infectious Disease, Dermatology, Immunology.

1998

Since

Drugs

Trials

New Drugs (2yr)

CARLSBAD's Key Drugs

CARLSBAD's key approved drugs from the last 15 years (excludes generics, biosimilars and IV formulations).

No active drugs

CARLSBAD's Recent FDA Approvals

CARLSBAD secured 1 new FDA approval for novel drugs (NDA/BLA) in the last two years.

FAMOTIDINE NDA

2025-07-16

famotidine

1 INDICATIONS AND USAGE Famotidine tablets are indicated in adult and pediatric patients 40 kg and greater for the treatment of: • active duodenal ulcer (DU). • active gastric ulcer (GU). • symptomatic nonerosive gastroesophageal reflux disease (GERD). • erosive esophagitis due to GERD, diagnosed by biopsy. Famotidine tablets are indicated in adults for the: • treatment of pathological hypersecretory conditions (e.g., Zollinger-Ellison syndrome, multiple endocrine neoplasias). • reduction of the risk of duodenal ulcer recurrence. Famotidine tablets are a histamine-2 (H 2 ) receptor antagonist indicated ( 1 ): In adult and pediatric patients 40 kg and greater for the treatment of: • active duodenal ulcer (DU). • active gastric ulcer. • symptomatic nonerosive gastroesophageal reflux disease (GERD). • erosive esophagitis due to GERD, diagnosed by biopsy. In adults for the: • treatment of pathological hypersecretory conditions (e.g., Zollinger-Ellison syndrome, multiple endocrine neoplasias). • reduction of the risk of DU recurrence.

CARLSBAD's Therapeutic Areas

CARLSBAD's approved drugs and pipeline span 5 therapeutic areas, led by Infectious Disease and Dermatology. Weighted by commercial stage — approved drugs count most, then late-stage trials.

Infectious Disease 29%

2 drugs

Dermatology 29%

2 drugs

Immunology 14%

1 drugs

Respiratory 14%

1 drugs

Gastroenterology 14%

1 drugs

CARLSBAD's Top Competitors

CARLSBAD's closest competitors by therapeutic-area and drug-target overlap include Pfizer, APOTHECON, and PHARMACIA AND UPJOHN. Ranked by overlap in therapeutic areas and drug targets across approved drugs and pipeline.

Pfizer big-pharma

Infectious Disease, Immunology, Dermatology

APOTHECON specialty

Infectious Disease, Dermatology, Gastroenterology, Respiratory

PHARMACIA AND UPJOHN big-pharma

Dermatology, Infectious Disease, Respiratory, Immunology

PF PRISM CV big-pharma

Infectious Disease, Dermatology, Immunology, Gastroenterology

Johnson & Johnson big-pharma

Immunology, Infectious Disease, Gastroenterology